• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射可穿越血脑屏障的结合物有助于生物大分子转运至中枢神经系统。

Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system.

作者信息

Wang Chang, Wang Siyu, Xue Yonger, Zhong Yichen, Li Haoyuan, Hou Xucheng, Kang Diana D, Liu Zhengwei, Tian Meng, Wang Leiming, Cao Dinglingge, Yu Yang, Liu Jayce, Cheng Xiaolin, Markovic Tamara, Hashemi Alice, Kopell Brian H, Charney Alexander W, Nestler Eric J, Dong Yizhou

机构信息

Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

Nat Biotechnol. 2024 Nov 25. doi: 10.1038/s41587-024-02487-7.

DOI:10.1038/s41587-024-02487-7
PMID:39587229
Abstract

Delivery of biomacromolecules to the central nervous system (CNS) remains challenging because of the restrictive nature of the blood-brain barrier (BBB). We developed a BBB-crossing conjugate (BCC) system that facilitates delivery into the CNS through γ-secretase-mediated transcytosis. Intravenous administration of a BCC10-oligonucleotide conjugate demonstrated effective transportation of the oligonucleotide across the BBB and gene silencing in wild-type mice, human brain tissues and an amyotrophic lateral sclerosis mouse model.

摘要

由于血脑屏障(BBB)的限制性,将生物大分子递送至中枢神经系统(CNS)仍然具有挑战性。我们开发了一种血脑屏障穿越偶联物(BCC)系统,该系统通过γ-分泌酶介导的转胞吞作用促进向中枢神经系统的递送。静脉注射BCC10-寡核苷酸偶联物证明寡核苷酸能有效穿过血脑屏障,并在野生型小鼠、人脑组织和肌萎缩侧索硬化小鼠模型中实现基因沉默。

相似文献

1
Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system.静脉注射可穿越血脑屏障的结合物有助于生物大分子转运至中枢神经系统。
Nat Biotechnol. 2024 Nov 25. doi: 10.1038/s41587-024-02487-7.
2
Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.脑穿透肽和肽药物偶联物克服血脑屏障并靶向中枢神经系统疾病。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1695. doi: 10.1002/wnan.1695. Epub 2021 Jan 20.
3
Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.从噬菌体展示文库中通过竞争洗脱分离血脑屏障穿透抗体及其穿透中枢神经系统的能力。
MAbs. 2018 Feb/Mar;10(2):304-314. doi: 10.1080/19420862.2017.1409320. Epub 2017 Dec 14.
4
Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry.虫媒脑炎病毒利用血脑屏障上的小窝介导的胞吞作用进入中枢神经系统。
mBio. 2020 Feb 11;11(1):e02731-19. doi: 10.1128/mBio.02731-19.
5
Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.血脑屏障(BBB)穿越策略,改善中枢神经系统疾病的治疗。
Handb Exp Pharmacol. 2024;284:213-230. doi: 10.1007/164_2023_689.
6
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.基于纳米材料的药物载体的设计与开发,利用不同的传输机制来克服血脑屏障。
Int J Mol Sci. 2021 Sep 19;22(18):10118. doi: 10.3390/ijms221810118.
7
The Metalloprotease, Mpr1, Engages AnnexinA2 to Promote the Transcytosis of Fungal Cells across the Blood-Brain Barrier.金属蛋白酶Mpr1与膜联蛋白A2结合,促进真菌细胞穿越血脑屏障的转胞吞作用。
Front Cell Infect Microbiol. 2017 Jun 30;7:296. doi: 10.3389/fcimb.2017.00296. eCollection 2017.
8
Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.利用受体介导的转胞吞作用将治疗剂通过血脑屏障递送至大脑的智能策略。
Chem Pharm Bull (Tokyo). 2020;68(4):316-325. doi: 10.1248/cpb.c19-00854.
9
Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.代谢型谷氨酸受体1的血脑屏障穿透性双特异性抗体拮抗剂的脑渗透、靶点结合及处置情况
FASEB J. 2016 May;30(5):1927-40. doi: 10.1096/fj.201500078. Epub 2016 Feb 2.
10
Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.使用基于人诱导多能干细胞的血脑屏障模型进行抗体筛选,可识别出在中枢神经系统中蓄积的抗体。
FASEB J. 2020 Sep;34(9):12549-12564. doi: 10.1096/fj.202000851R. Epub 2020 Jul 30.

引用本文的文献

1
Lipid nanoparticles for mRNA delivery in brain via systemic administration.通过全身给药用于脑内mRNA递送的脂质纳米颗粒。
Sci Adv. 2025 Aug 15;11(33):eadw0730. doi: 10.1126/sciadv.adw0730. Epub 2025 Aug 13.
2
Vagus nerve stimulation: innovative applications in the field of hand function rehabilitation.迷走神经刺激:手部功能康复领域的创新应用
Cogn Neurodyn. 2025 Dec;19(1):98. doi: 10.1007/s11571-025-10284-4. Epub 2025 Jun 23.
3
Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment.

本文引用的文献

1
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier.针对转铁蛋白受体将反义寡核苷酸转运穿过哺乳动物血脑屏障。
Sci Transl Med. 2024 Aug 14;16(760):eadi2245. doi: 10.1126/scitranslmed.adi2245.
2
An AAV capsid reprogrammed to bind human transferrin receptor mediates brain-wide gene delivery.经重编程后能够与人转铁蛋白受体结合的腺相关病毒衣壳可介导全脑范围的基因递送。
Science. 2024 Jun 14;384(6701):1220-1227. doi: 10.1126/science.adm8386. Epub 2024 May 16.
3
Drug delivery to the central nervous system.
用于阿尔茨海默病治疗的小胶质细胞中Aβ-STING反馈机制的纳米免疫调节
Proc Natl Acad Sci U S A. 2025 Jun 3;122(22):e2427257122. doi: 10.1073/pnas.2427257122. Epub 2025 May 28.
4
Unlock the sustained therapeutic efficacy of mRNA.释放信使核糖核酸的持续治疗效果。
J Control Release. 2025 Jul 10;383:113837. doi: 10.1016/j.jconrel.2025.113837. Epub 2025 May 12.
5
Alzheimer's Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory.阿尔茨海默病是一种由独立于淀粉样前体蛋白(AβPP)产生的C99片段驱动的持续性神经元综合应激反应的多形性疾病;在受阿尔茨海默病影响的神经元中,Aβ的蛋白水解产生受到抑制:一种理论的演变
Int J Mol Sci. 2025 Apr 29;26(9):4252. doi: 10.3390/ijms26094252.
6
Refining Lung Cancer Brain Metastasis Models for Spatiotemporal Dynamic Research and Personalized Therapy.优化用于时空动态研究和个性化治疗的肺癌脑转移模型
Cancers (Basel). 2025 May 7;17(9):1588. doi: 10.3390/cancers17091588.
7
Elucidating neuroepigenetic mechanisms to inform targeted therapeutics for brain disorders.阐明神经表观遗传机制以为脑部疾病的靶向治疗提供依据。
iScience. 2025 Feb 22;28(3):112092. doi: 10.1016/j.isci.2025.112092. eCollection 2025 Mar 21.
药物向中枢神经系统的递送。
Nat Rev Mater. 2022 Apr;7(4):314-331. doi: 10.1038/s41578-021-00394-w. Epub 2021 Dec 3.
4
Chemically Modified Platforms for Better RNA Therapeutics.化学修饰平台提高 RNA 治疗效果
Chem Rev. 2024 Feb 14;124(3):929-1033. doi: 10.1021/acs.chemrev.3c00611. Epub 2024 Jan 29.
5
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs.双特异性抗体穿梭靶向 CD98hc 介导 IgG 高效且持久的脑部递释。
Cell Chem Biol. 2024 Feb 15;31(2):361-372.e8. doi: 10.1016/j.chembiol.2023.09.008. Epub 2023 Oct 26.
6
The amyotrophic lateral sclerosis exposome: recent advances and future directions.肌萎缩侧索硬化症外显子组:最新进展与未来方向。
Nat Rev Neurol. 2023 Oct;19(10):617-634. doi: 10.1038/s41582-023-00867-2. Epub 2023 Sep 14.
7
Alternative splicing in neurodegenerative disease and the promise of RNA therapies.神经退行性疾病中的可变剪接与 RNA 疗法的前景。
Nat Rev Neurosci. 2023 Aug;24(8):457-473. doi: 10.1038/s41583-023-00717-6. Epub 2023 Jun 19.
8
The blood-brain barrier: structure, regulation, and drug delivery.血脑屏障:结构、调控与药物递送。
Signal Transduct Target Ther. 2023 May 25;8(1):217. doi: 10.1038/s41392-023-01481-w.
9
Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.靶向 Tau 的反义寡核苷酸 MAPT 治疗轻度阿尔茨海默病的 1b 期、随机、安慰剂对照试验。
Nat Med. 2023 Jun;29(6):1437-1447. doi: 10.1038/s41591-023-02326-3. Epub 2023 Apr 24.
10
An RNA-based system to study hepatitis B virus replication and evaluate antivirals.基于 RNA 的乙型肝炎病毒复制研究和抗病毒药物评估系统。
Sci Adv. 2023 Apr 14;9(15):eadg6265. doi: 10.1126/sciadv.adg6265. Epub 2023 Apr 12.